Tweets
The RheumNow Podcast is up! This time its a Late Breaking Abstract Wrap-Up. Watch it here>> https://t.co/ZoVE5gSdG9 or Podcast listen on iTunes, in your car on Apple Car play or on SoundCloud here>> https://t.co/6AwVH1Zjoy
😲
Dr. John Cush @RheumNow ( View Tweet )
7 years 1 month ago
Give me your take for my next ED in @HealioRheum on DTC-Direct to-consumer adverstising of Drugs/Biologics (as seen on national TV news : I am reasonably in favor of ( @psufka @DrBhana @AngusWorthing @RheumNow @autoimmunitymd @AutoimmuneList @SjogrensOrg )
Leonard Calabrese @LCalabreseDO ( View Tweet )
7 years 1 month ago
CDC reports a 3-10mos shortage of Aplisol, a PPD product. Another PPD product, Tubersol is available for skin testing. CDC recs to use IGRA blood tests for TST & prioritize TSTs. Switching from PPD to IGRA may result in conversions requiring interpretation https://t.co/eJGOHVCbkO
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 1 month ago
"Clinicians should assess test results based on the person's likelihood of infection and risk for progression to TB disease, if infected," according to the CDC.
MMWR. 2019;68:552-553. https://t.co/eJGOHVCbkO
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 1 month ago
Hear nine experts talk about biosimilars in “Therapeutic Update: Biosimilars in Rheumatology”, a video series brought to viewers by Sandoz. Now available on RheumNow. https://t.co/1vmnEJqOSi #sponsored #biosimilars https://t.co/EXf19NB6g8
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 1 month ago
Lupus Research Alliance has awarded 2019 Lupus Insight Prize to Ignacio Sanz, MD, (Chief of Rheumatology, Emory Univ School of Medicine) for discovering that molecular mechanisms that underpin B cell activation pathway promoting lupus symptoms. https://t.co/RKFprO2wwj
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 1 month ago
FORWARD, a National Databank study, looked at malignancies & infections in RA pts starting abatacept, other biologicsor DMARDs. No difference in cancer risks, but ABA had lower risk hospitalized infx (HR 0.37) & lower infusion/injx rxn than other biologics https://t.co/9GonhVTK3Z
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 1 month ago
Methotrexate assoc. lymphoproliferative disorders (LPDs), is a rare disorder that resolves w/ MTX withdrawal (in 3-10mos). Most common path was diffuse large B-cell lymphoma and 45-77% had Epstein-Barr virus encoded RNA positivity. https://t.co/xF8YLiI2lc
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 1 month ago
#EULAR2019 Emapalumab - a monoclonal Ab against IFNγ - was shown to be effective in 6 systemic JIA patients with macrophage activation syndrome. Rx led to rapid neutralization of IFNγ, normalization of CXCL9, & decreased T cell activation. OP0204 https://t.co/5K58IUNdCV
Dr. John Cush @RheumNow ( View Tweet )
7 years 1 month ago
A survey of 900 Danish rheumatic dz pts shows that 1 in 10 with pain have considered suicide in the last 4 weeks and that this was strongly influenced by poor quality sleep. #EULAR2019 OP0347 https://t.co/hfIWXEC4Xo
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 1 month ago
#EULAR2019 Come hear the latest on gout! Room N103 16:15-17:45 today. Risk:Exciting new genetics, occupational hazard, diet and inflammation. Treatment: New effectiveness measure, DECT to diagnose, flare prophylaxis, treat to target to prevent increased mortality @rheumnow #gout
Gout Study Group @GoutGroup ( View Tweet )
7 years 1 month ago
#Gout and #genetics at #EULAR2019. New data on genes linked to sUA regulation and leading-edge genetics on conversion from #hyperuricemia to gout were shown in talks OP47 and OP48 @Rheumnow https://t.co/d6pikodu6K
Gout Study Group @GoutGroup ( View Tweet )
7 years 1 month ago
A study examined whether EGCG suppresses the activation of the NLRP3 inflammasome, thereby effectively preventing gouty #inflammation. It was found that EGCG reduces inflammation in mouse foot tissue making it a promising treatment option for #gout https://t.co/X9O2mbJx6A https://t.co/wgUYz0BmeY
Gout Study Group @GoutGroup ( View Tweet )
7 years 1 month ago
PARE poster tour II: @SjogrenpowerAna presenting poster “Patient Voice in Gout: A European Patient Survey to understand the needs of people living with #gout” #agony (37%) #frustation (32%) inconvenience (53%) & 10% of patients have retired because of gout #Time2Work #EULAR2019 https://t.co/qUQoYt3nKL
Victoria Romero @romeropazosvic ( View Tweet )
7 years 1 month ago
Achilles’ tendon issues can be painful and disabling, and are something we all want to avoid. Dr Simon Otter presents imaging data at #EULAR2019 showing loss of Achilles’ tendon stiffness-ability to bear load-in the gout patients in his cohort. Abstract SAT0727 #gout @RheumNow https://t.co/yxhcpQsGBi
Gout Study Group @GoutGroup ( View Tweet )
7 years 1 month ago
